Article Information
PubMed
Published By
History
- Received February 5, 2019
- Accepted February 8, 2019
- Published online February 25, 2019.
Copyright & Usage
Copyright © 2019 Liu and Baraban This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
Author Information
Author contributions
Author contributions: J.L. and S.C.B. designed research; J.L. and S.C.B. performed research; J.L. analyzed data; J.L. and S.C.B. wrote the paper.
Disclosures
S.C.B. is a co-Founder and Scientific Advisor for EpyGenix Therapeutics. J.L. declares no competing financial interests.
This work was supported by National Institutes of Health/National Institute of Neurological Disorders and Stroke Grants R01-NS096976 and R01-NS103139 and by a University of California San Francisco - University of California Berkeley (UCSF-UCB) Sackler Family Exchange sabbatical fellowship (to S.C.B.).
Funding
HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS)
R01-NS096976; R01-NS103139
Other Version
- You are viewing the most recent version of this article.
- previous version (February 25, 2019).